A vancomycin-resistant, anaerobic, gram-positive coccus containing the vanD and vanG-like genes (strain CCRI-16110) was isolated from a human fecal specimen during a hospital surveillance program to detect carriers of vancomycin-resistant enterococci. Comparison of the 16S rRNA gene sequence of strain CCRI-16110 with databases revealed a potentially novel Ruminococcus species that was most similar (<94% identity) to Clostridium and Ruminococcus species. Strain CCRI-16110 was highly resistant to vancomycin and teicoplanin (MICs of >256 g/ml). The complete DNA sequence of the vanD cluster was most similar (98.2% identity) to that of Enterococcus faecium BM4339, containing the vanD1 allele. An intD gene with 99% identity with that of this E. faecium strain was found to be associated with the vanD gene cluster of this novel anaerobic bacterium. Strain CCRI-16110 also harbors genes encoding putative VanS G , VanG, and VanT G proteins displaying 56, 73.6, and 55% amino acid sequence identity, respectively, compared to the corresponding proteins encoded by the vanG1 and vanG2 operons of Enterococcus faecalis BM4518 and N03-0233. This study reports for the first time an anaerobic bacterium containing the vanD gene cluster. This strain also harbors a partial vanG-like gene cluster. The presence of vanD-and vanG-containing anaerobic bacteria in the human bowel flora suggests that these bacteria may serve as a reservoir for the vanD and vanG vancomycin resistance genes.The glycopeptide antibiotics vancomycin and teicoplanin interfere with cell wall synthesis in gram-positive bacteria by binding to the terminal dipeptide D-alanyl-D-alanine regions of the pentapeptide precursors of peptidoglycan side chains. Resistance to glycopeptide antibiotics was first described for enterococci (23, 35) and has now spread worldwide. Six different genes (vanA, vanB, vanC, vanD, vanE, and vanG) have been shown to confer glycopeptide resistance in enterococci (7).The VanD-type resistance is constitutively expressed in enterococci (8, 11) and is characterized by moderate MICs of vancomycin (64 to 128 g/ml) and teicoplanin (4 to 64 g/ml). This VanD-type resistance results from the acquisition of the vanR D , vanS D , vanY D , vanH D , vanD, and vanX D cluster of genes, which directs synthesis of peptidoglycan precursors terminating in D-alanyl-D-lactate (11). The vanD gene cluster is located on the chromosome and is not transferable to other enterococci by conjugation in vitro (11). The VanD-type resistance in enterococci is also characterized by the presence of an impaired D-alanyl-D-alanine (Ddl) ligase due to mutations in the chromosomal ligase-encoding gene ddl (10). Although the Ddl ligase is inactive, the VanD-type enterococci are able to grow even in the absence of glycopeptide because the vanD cluster is expressed constitutively as a result of mutations in the VanS D sensor or in the VanR D regulator (10).The VanG-type resistance in enterococci is characterized by low-level resistance to vancomycin (MIC, 16 g/ml) and susceptibility t...